Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,564 | 205 | 84.4% |
| Travel and Lodging | $846.00 | 2 | 15.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nevro Corp. | $1,553 | 26 | $0 (2023) |
| ABBVIE INC. | $808.01 | 33 | $0 (2024) |
| Boston Scientific Corporation | $553.12 | 22 | $0 (2024) |
| Medtronic, Inc. | $483.97 | 32 | $0 (2024) |
| Abbott Laboratories | $384.34 | 21 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $211.55 | 8 | $0 (2022) |
| MML US, Inc. | $175.59 | 2 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $165.87 | 10 | $0 (2024) |
| Relievant Medsystems, Inc. | $140.98 | 3 | $0 (2023) |
| Lundbeck LLC | $139.63 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,286 | 55 | ABBVIE INC. ($423.71) |
| 2023 | $973.82 | 34 | Nevro Corp. ($241.10) |
| 2022 | $2,233 | 55 | Nevro Corp. ($1,288) |
| 2021 | $916.93 | 63 | Abbott Laboratories ($226.63) |
All Payment Transactions
207 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $3.11 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/20/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/07/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.80 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/25/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/12/2024 | Boston Scientific Corporation | Artisan (Device) | Food and Beverage | In-kind items and services | $29.82 | General |
| Category: Artisan_NMD | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: PAIN | ||||||
| 11/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Gastroenterology | ||||||
| 11/06/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $15.03 | General |
| Category: NEUROLOGY | ||||||
| 11/01/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/30/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $30.11 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/11/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Gastroenterology | ||||||
| 10/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.31 | General |
| Category: Opioid Analgesic | ||||||
| 09/27/2024 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 09/25/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $9.61 | General |
| Category: EndoVenous Therapies | ||||||
| 09/23/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $5.03 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/03/2024 | MML US, Inc. | ReActiv8 (Device) | Food and Beverage | Cash or cash equivalent | $32.30 | General |
| Category: Pain Management | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Gastroenterology | ||||||
| 08/22/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $33.98 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $28.07 | General |
| 07/31/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $30.24 | General |
| 07/29/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: Spinal Cord Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 991 | 2,079 | $1.0M | $164,310 |
| 2022 | 8 | 1,008 | 2,133 | $994,151 | $150,035 |
| 2021 | 9 | 773 | 1,404 | $607,051 | $95,680 |
| 2020 | 11 | 1,465 | 2,798 | $777,126 | $161,746 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 525 | 1,342 | $756,888 | $101,702 | 13.4% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 98 | 142 | $82,502 | $27,657 | 33.5% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 52 | 57 | $42,921 | $13,793 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 183 | 262 | $104,014 | $13,753 | 13.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $21,930 | $2,751 | 12.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 26 | $20,514 | $2,495 | 12.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 24 | 28 | $7,812 | $1,332 | 17.1% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 12 | 17 | $4,590 | $680.43 | 14.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 46 | 175 | $2,625 | $145.20 | 5.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 514 | 1,280 | $721,920 | $97,554 | 13.5% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 82 | 119 | $69,139 | $23,322 | 33.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 213 | 329 | $130,613 | $17,901 | 13.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $33,626 | $4,226 | 12.6% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 12 | 13 | $9,789 | $3,168 | 32.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 42 | 46 | $12,834 | $1,916 | 14.9% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2022 | 30 | 46 | $12,420 | $1,740 | 14.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 69 | 254 | $3,810 | $207.86 | 5.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 400 | 847 | $456,017 | $66,141 | 14.5% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 44 | 47 | $27,307 | $9,341 | 34.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 138 | 178 | $59,716 | $8,531 | 14.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 48 | 49 | $35,321 | $5,087 | 14.4% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 13 | 14 | $10,542 | $3,457 | 32.8% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 19 | 22 | $6,192 | $1,072 | 17.3% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 65 | 80 | $4,000 | $1,008 | 25.2% |
| 20553 | Injections of trigger points in 3 or more muscles | Office | 2021 | 13 | 22 | $5,781 | $906.07 | 15.7% |
About Brian Jorgensen
Brian Jorgensen is a Physician Assistant healthcare provider based in St George, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/18/2014. The National Provider Identifier (NPI) number assigned to this provider is 1790187904.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brian Jorgensen has received a total of $5,410 in payments from pharmaceutical and medical device companies, with $1,286 received in 2024. These payments were reported across 207 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,564).
As a Medicare-enrolled provider, Jorgensen has provided services to 4,237 Medicare beneficiaries, totaling 8,414 services with total Medicare billing of $571,770. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Other Specialties Medical
- Location St George, UT
- Active Since 09/18/2014
- Last Updated 03/29/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1790187904
Products in Payments
- Senza (Device) $1,403
- BOTOX (Biological) $474.97
- INTELLIS ADAPTIVESTIM (Device) $410.66
- NURTEC ODT (Drug) $274.16
- UBRELVY (Drug) $236.42
- GENERAL PAIN MANAGEMENT (Device) $221.97
- ReActiv8 (Device) $175.59
- Octrode SCS Leads (Device) $172.12
- RELISTOR (Drug) $165.87
- QULIPTA (Drug) $161.75
- SUPERA (Device) $157.71
- Omnia (Device) $149.63
- Intracept (Device) $140.98
- VYEPTI (Biological) $139.63
- Movantik (Drug) $118.79
- Nalu Neurostimulation System (Device) $110.80
- XTAMPZA (Drug) $92.61
- AJOVY (Biological) $86.65
- Aimovig (Biological) $81.43
- CoverEdge 32 (Device) $76.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in St George
Daniel Corry, Pa, PA
Physician Assistant — Payments: $8,785
Helle Brand, Pa-C, PA-C
Physician Assistant — Payments: $7,848
Cortney Bernardo, Pac, PAC
Physician Assistant — Payments: $7,440
Mr. Justin Poole, Pa, PA
Physician Assistant — Payments: $5,598
Tim Nowatzke, P.a.-C, P.A.-C
Physician Assistant — Payments: $5,032
Kylie Fackrell, Pa-C, PA-C
Physician Assistant — Payments: $4,329